Y(

Yi (Lily) Li

Sr. Director-Medical-Accelerated R&D Leadership Program at Eli Lilly and Company

Toronto, Ontario

Overview

Work Experience

EL

Eli Lilly and Company

  • Sr. Director-Medical-Accelerated R&D Leadership Program

    2024 - Current

RR

Red Ridge Bio

  • Board Observer

    2024 - 2024

LT

Libra Therapeutics

  • Board Observer

    2020 - 2024

SD

Sixty Degree Capital

  • Managing Director

    2018 - 2024

    - Lead healthcare investments - Directed investments into companies and funds including Schrödinger, Monte Rosa Therapeutics, Cincor Pharma, Arcellx Inc, NextPoint Therapeutics, Strive Health, Everside Health, Korro Bio, Turnstone Biologics, Northern Biologics, Engage Therapeutics, Pipeline Therapeutics, Transthera, and many more. - Passionate about drug development and making a difference in people’s life. - Supportive of both the scientific and business aspects of new ideas and start-ups with the goal of bringing new therapies and technologies to patients.

SH

Strive Health

  • Investor

    2023 - 2023

KB

Korro Bio, Inc.

  • Investor

    2022 - 2023

TB

Turnstone Biologics

  • Investor

    2019 - 2023

AT

Antios Therapeutics

  • Board Observer

    2018 - 2023

Education

Relevant Websites